Clinical Trials Browser

Phase EARLY_PHASE1 × AML × Clear all

NCT05239689 2022-02-15

Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies

Phase EARLY_PHASE1 Unknown

AML